Concord Biotech Ltd Q4 FY2023-2024 Results: Summary

Revenue
₹329.78Cr
Net Profits
₹95.02Cr
Net Profit Margins
28.81%

Highlights

Revenue:

Concord Biotech Ltd’s revenue jumped 15.8% since last year same period to ₹329.78Cr in the Q4 2023-2024. On a quarterly growth basis, Concord Biotech Ltd has generated 30.87% jump in its revenue since last 3-months.

Net Profits:

Concord Biotech Ltd’s net profit jumped 3.86% since last year same period to ₹95.02Cr in the Q4 2023-2024. On a quarterly growth basis, Concord Biotech Ltd has generated 22.5% jump in its net profits since last 3-months.

Net Profit Margins:

Concord Biotech Ltd’s net profit margin fell -10.31% since last year same period to 28.81% in the Q4 2023-2024. On a quarterly growth basis, Concord Biotech Ltd has generated -6.4% fall in its net profit margins since last 3-months.

FAQs

The revenue for Concord Biotech Ltd in the Q4 results 2023 was ₹329.78Cr.

The net profit for Concord Biotech Ltd in the Q4 results 2023 was ₹95.02Cr.

The net profit margin for Concord Biotech Ltd in the Q4 results 2023 was 28.81%.

The revenue for Concord Biotech Ltd in the Q4 results 2022 was ₹284.79Cr.

The net profit for Concord Biotech Ltd in the Q4 results 2022 was ₹91.49Cr.

The net profit margin for Concord Biotech Ltd in the Q4 results 2022 was 32.13%.